NCT03554174: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
- State
- Under way
- Phase
- Phase 1
- People
- 18 planned
- Started
- 27 Feb 2018
- Primary completion
- 8 Jul 2021
- Arms
- Placebo/Low Dose Psilocybin, Placebo/Medium Dose Psilocybin, Low Dose Psilocybin/Placebo, Medium Dose Psilocybin/Placebo
- Results
- None posted
- 27 Feb 2018: Trial started
- 13 Jun 2018: Trial registered